CME and CFTC Engage in Battle Over On-Chain Perpetual Futures

The ongoing dispute between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission, has reached a boiling point. The controversy centers around the CFTC's decision to allow the listing of blockchain-based perpetual future products, which the CME claims are being mislabeled and misregulated. The CME has filed a lawsuit against the CFTC, arguing that these products, known as perps, are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The CFTC, on the other hand, believes that its decision to allow perps is a necessary step towards regulating the rapidly growing cryptocurrency market. As the two sides await federal court action, the outcome of this battle could have significant implications for the US approach to the crypto market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME's concerns over the CFTC's regulatory approach are rooted in its belief that perps are not futures, but rather swaps, which are subject to different regulatory requirements. The CFTC, however, has determined that a case-by-case review process is suitable for perps, and has approved the listing of these products on platforms such as Kalshi and Coinbase. The dispute between the CME and CFTC has sparked a heated debate, with some arguing that the CME is attempting to stifle innovation and competition, while others believe that the CFTC is overstepping its regulatory bounds. As the situation continues to unfold, it remains to be seen how the US will approach the regulation of the crypto market, and what the implications will be for the CME, the CFTC, and the broader financial industry.